ATRA: Atara Biotherapeutics, Inc. Sotuvga nisbatan narx
Atara Biotherapeutics Kaliforniyadagi o'z ishlab chiqarish korxonasi orqali dori ishlab chiqarishning barqaror zanjirini saqlab qolmoqda, garchi biotexnologiya gigantlarining shiddatli raqobati sezilarli xatarlarni yuzaga keltirsa-da. Kompaniyaning narx/savdo ko'rsatkichi spekulyativ baholash buzilishlarini ochib beradi, bunda joriy parametr 20.30 darajasida turibdi. Yevropa Ittifoqida terapiyaning yuqori narxi narxlarni belgilash imkoniyatini beradi, ammo tor bemorlar bazasi biznesning umumiy monetizatsiyasini cheklaydi.
Atara Biotherapeutics (ATRA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Atara Biotherapeutics|ATRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati atarabio.com|ATRA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Atara Biotherapeutics Inc|ATRA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Atara Biotherapeutics|Tezkor likvidlik atarabio.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ATRA - Sof foyda|Kompaniya foydasi prognozi Atara Biotherapeutics|ATRA - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati atarabio.com|ATRA - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Atara Biotherapeutics Inc|ATRA - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Atara Biotherapeutics|ATRA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi atarabio.com|ATRA - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Atara Biotherapeutics
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning umumiy tahlili:ATRA Atara Biotherapeutics, Inc.
P/S koeffitsienti tushumlar dinamikasiga sezgir bo'lib, biznesning bozor qiymatini uning savdo hajmi bilan nisbatda aks ettiradi. Ushbu koeffitsient vaqtincha yo'qotishlarning ta'sirini istisno qilish orqali kompaniya kapitalizatsiyasining adolatliligini baholash imkonini beradi. Atara Biotherapeutics (ATRA) uchun ushbu hisob-kitob allogeneik immunoterapiyadagi innovatsiyalar qiymatini va inqilobiy dori vositalariga bo'lgan bozor ishonchini tasdiqlaydi. P/S grafigini tahlil qilish orqali investor narx anomaliyalarini va aktivlarning haddan tashqari yuqori baholanishi risklarini zudlik bilan aniqlashi mumkin.
Atara Biotherapeutics kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|IMVT (Immunovant, Inc.) - Kapitalizatsiyaning daromadga nisbati|KNSA: Kapitalizatsiyaning sotish hajmiga nisbati|GRFS (Grifols) - P/S multiplikatori|P/S multiplikatori Adaptive Biotech|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|P/S multiplikatori veratx.com VERA|DNTH: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PHVS (Pharvaris NV)|ABCL: P/S multiplikatori|TRML (Tourmaline) - Narxning daromadga nisbati|PGEN (Precigen, Inc.) - P/S multiplikatori|pharming.com (PHAR) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Nektar Therapeutics Inc. (NKTR)|UPB - Sotuvga nisbatan narx|Zenas Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati IMNM (Immunome Bio)|Gossamer Bio, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|SEPN: P/S multiplikatori|Sotuvga nisbatan narx Pieris Pharma (PVLA)|Narxning daromadga nisbati Savara Corp|RIGL: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ANAB|P/S multiplikatori astriatx.com (ATXS)|Narxning daromadga nisbati enGene ENGN|RAPT (RAPT Therapeutics Inc.) - Narxning sotuvga nisbati|Aerovate - P/S multiplikatori|Sotuvga nisbatan narx Aclaris Therapeutics, Inc|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|tizianalifesciences.com (TLSA) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CABA|VTYX (Ventyx Biosciences Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori THTX|Narx/daromad koeffitsiyenti Avalo Therapeutics Inc|P/S multiplikatori ELDN (Eledon Pharmaceuticals)|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Zura Bio Ltd ZURA|ATYR: P/S multiplikatori|Adagene Inc. (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|STTK (Shattuck Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori IMUX (Immunic)|P/S multiplikatori InflaRx NV IFRX|XFOR - Narxning daromadga nisbati|Narxning sotuvga nisbati ACET|CELU: P/S multiplikatori|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|BRNS (Barinthus Bio) - P/S multiplikatori|P/S multiplikatori Kezar Life Sciences Inc|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|AKTX (akaritx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalizatsiyaning daromadga nisbati|GeoVax Labs Inc - P/S multiplikatori|EDSA - P/S multiplikatori|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Carisma Therapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Bolt Bio (BOLT) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Kapitalizatsiyaning daromadga nisbati aptevotherapeutics.com APVO|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI: Kapitalizatsiyaning daromadga nisbati|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|INDP (Indaptus Therapeutics) - P/S multiplikatori|Sotuvga nisbatan narx scinai.com SCNI|P/S multiplikatori CALI|P/S multiplikatori affimed.com (AFMD)|Allakos - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGM Bio - P/S multiplikatori|ITOS - P/S multiplikatori|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|TC BioPharm (Holdings) Plc - Bozor kapitallashuvining daromadga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
